INBX Stock: Price, Earnings History and SEC Filings
Inhibrx Biosciences, Inc. (INBX) last traded at $71.78, down 2.54% on the latest session and down 28.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-2.34 against an analyst estimate of $-2.50, a beat of 6.4%.
$71.78 -2.54%
1 month-28.28%
52-week high$155.29
52-week low$57.30
Volume438,828
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
INBX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 13, 2026 | $-2.34 | $-2.50 | +6.40% |
| Mar 2026 | May 14, 2026 | $-2.15 | $-2.37 | +9.28% |
INBX beat the analyst EPS estimate in 2 of its last 2 reported quarters. Source: Nasdaq.
Latest SEC filings for INBX
SEC filing data is not available right now. You can search for INBX on SEC EDGAR.
INBX news
- Inhibrx Biosciences (INBX) Stock Looks Hard To Pin Down At This PriceOct 23, 2026 · finance.yahoo.com
- Insiders Load Up on These 2 ‘Strong Buy’ Stocks — Should You Follow Their Footsteps?Oct 21, 2026 · finance.yahoo.com
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. (INBX) is a US-listed public company on Nasdaq.